相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
Eleni G. Iliopoulou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia
Andrea Velardi et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
Maria Berg et al.
CYTOTHERAPY (2009)
Natural killer cell-based immunotherapy in cancer: current insights and future prospects
T. Sutlu et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells
Laurent Boissel et al.
LEUKEMIA RESEARCH (2009)
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56BrightCD16- cells and display an impaired capability to kill tumor cells
Paolo Carrega et al.
CANCER (2008)
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy
Karl-Johan Malmberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Artificial cells for the development of cell therapy
Naoya Kobayashi
CELL TRANSPLANTATION (2008)
Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation
Cai Zhang et al.
CYTOKINE (2008)
Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL
W. Jiang et al.
CYTOTHERAPY (2008)
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
S. Arai et al.
CYTOTHERAPY (2008)
Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells
Tina Mueller et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
The trafficking of natural killer cells
Claude Gregoire et al.
IMMUNOLOGICAL REVIEWS (2007)
Proteomic analysis of human NK-92 cells after NK cell-mediated cytotoxicity against K562 cells
Xi-Cheng Liu et al.
BIOCHEMISTRY-MOSCOW (2007)
Prospects for the use of NK cells in immunotherapy of human cancer
Hans-Gustaf Ljunggren et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer
Hans J. J. van der Vliet et al.
CLINICAL CANCER RESEARCH (2007)
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression
Francois Ghiringhelli et al.
IMMUNOLOGICAL REVIEWS (2006)
Activation, coactivation, and costimulation of resting human natural killer cells
Yenan T. Bryceson et al.
IMMUNOLOGICAL REVIEWS (2006)
Cytolytic and cytotoxic activity of a human natural killer cell line genetically modified to specifically recognize HER-2/neu overexpressing tumor cells
F. J. Demirtzoglou et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2006)
Irradiated KHYG-1 retains cytotoxicity: Potential for adoptive immunotherapy with a natural killer cell line
G. Suck et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2006)
Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma
C Fauriat et al.
LEUKEMIA (2006)
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: A preclinical study
JK Chan et al.
CLINICAL CANCER RESEARCH (2006)
Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas
M Jinushi et al.
JOURNAL OF HEPATOLOGY (2005)
KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity
G Suck et al.
EXPERIMENTAL HEMATOLOGY (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Natural killer cell-based immunotherapeutic strategies
HG Klingemann
CYTOTHERAPY (2005)
Targeting IL-2 to the endoplasmic reticulum confines autocrine growth stimulation to NK-92 cells
KV Konstantinidis et al.
EXPERIMENTAL HEMATOLOGY (2005)
Cytokines in cancer immunity and immunotherapy
MJ Smyth et al.
IMMUNOLOGICAL REVIEWS (2004)
Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells
C Bottino et al.
MOLECULAR IMMUNOLOGY (2004)
Different checkpoints in human NK-cell activation
L Moretta et al.
TRENDS IN IMMUNOLOGY (2004)
Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells
YG He et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells
T Igarashi et al.
BLOOD (2004)
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity
P Mirandola et al.
BLOOD (2004)
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial
LJ Burns et al.
BONE MARROW TRANSPLANTATION (2003)
Ex vivo purging with NK-92 prior to autografting for chronic myelogenous leukemia
G Maki et al.
BONE MARROW TRANSPLANTATION (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Preferential apoptosis of CD56(dim) natural killer cell subset in patients with cancer
T Bauernhofer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy
YK Tam et al.
CYTOTHERAPY (2003)
In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells
MA Cooper et al.
BLOOD (2002)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
SS Farag et al.
BLOOD (2002)
Interleukin-2 and interleukin-15: immunotherapy for cancer
TA Fehniger et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Interleukin 2 and interleukin 15 differentially predispose natural killer cells to apoptosis mediated by endothelial and tumour cells
L Rodella et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Natural killer cells, viruses and cancer
A Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2001)
The biology of natural killer cells in cancer, infection, and pregnancy
JS Miller
EXPERIMENTAL HEMATOLOGY (2001)
Chimeric antigen receptors for the retargeting of cytotoxic effector cells
C Uherek et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92
T Tonn et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92
G Maki et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Interleukin 15: biology and relevance to human disease
TA Fehniger et al.
BLOOD (2001)
A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation
M Yagita et al.
LEUKEMIA (2000)
Malignant hematopoietic cell lines:: in vitro models for the study of natural killer cell leukemia-lymphoma
HG Drexler et al.
LEUKEMIA (2000)
Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer
M deMagalhaes-Silverman et al.
JOURNAL OF IMMUNOTHERAPY (2000)
分享论文
